DE3521456
Compounds of formula (II> in which R1 is C1-4 alkyl, preferably methyl, are prepared by reaction of a compound of formula (I> where Q is hydrogen or a cation derived from a suitable base with a suitable alkylating agent such as an alkyl halide or a dialkyl sulphate. The compound of formula (II...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
29.04.1993
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Compounds of formula (II> in which R1 is C1-4 alkyl, preferably methyl, are prepared by reaction of a compound of formula (I> where Q is hydrogen or a cation derived from a suitable base with a suitable alkylating agent such as an alkyl halide or a dialkyl sulphate. The compound of formula (II) may be converted into a histamine H2-antagonist containing an -NHC(=CHNO2)NHCH3 end group, e.g. ranitidine, by reaction with an appropriate amine. The compound of formula (I) (compounds where Q is H or alkali metal are said to be novel) may be prepared by reaction of methyl isothiocyanate with the carbanion of nitromethane (preferably generated in situ by reaction of nitromethane with a suitable base) in the presence of dimethyl sulphoxide as solvent, Q representing the cation derived from the base used to produce the carbanion of nitromethane. |
---|---|
Bibliography: | Application Number: DE19853521456 |